Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common stock, par value $0.001 per share
-
Shares outstanding
-
37,972,605
-
Total 13F shares
-
30,077,083
-
Share change
-
+2,630,115
-
Total reported value
-
$1,028,007,222
-
Price per share
-
$34.18
-
Number of holders
-
75
-
Value change
-
+$90,244,510
-
Number of buys
-
49
-
Number of sells
-
20
Institutional Holders of iTeos Therapeutics, Inc. - Common stock, par value $0.001 per share (ITOS) as of Q1 2021
As of 31 Mar 2021 iTeos Therapeutics, Inc. - Common stock, par value $0.001 per share (ITOS) had 75 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 30,077,083 shares of stock of the company.
Largest 10 holders included RA CAPITAL MANAGEMENT, L.P., BOXER CAPITAL, LLC, MPM ASSET MANAGEMENT LLC, RTW INVESTMENTS, LP, MPM Oncology Impact Management LP, BlackRock Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., JANUS HENDERSON GROUP PLC, ALLIANCEBERNSTEIN L.P., and Artal Group S.A..
This table shows 75 institutional shareholders of the security as of 31 Mar 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.